AT1

0.00%

2.4¢ atomo diagnostics limited

And the revenue doesn't include the sales relate to covid-19 per...

First 330 Last

Share
Profile

Follow
Soul13

520 Posts.

93

12/05/20

20:48

Post #: 44583126
Share

Originally posted by Delcos66: ↑

Its clear as day to me. Atomo had sold 1.2M devices over the past 3 years. Atomos last 3 orders from NG Biotech now total 1.39M devices through to 31st July 2020. Atomos 3 orders from NG Biotech are already greater than the total number of devices ever sold.

This is only the beginning for Atomo. I have found countless articles that say TODAY, NG Biotech can produce hundreds of thousands of tests. But their plan is to produce 1-2M tests per month from July onwards. This is in-line with Atomos additional capacity that will come online in July.

NG Biotech is the ONLY approved company to market its rapid diagnostic serological test "NG-Test IgG-IgM Covid 19" in France. This is clinically validated in France and has European approval. The first customer was the French Army, and now a 15k person trial (13k health workers and 2k patients) is underway over 10 hospitals and health centers over the ille-et-vilaine region. NG Biotech is making serious progress in France and Atomo will be apart of this.

Only just last week, NG Biotech entered into an agreement with Eurobio Scientific for the distribution in France of the rapid diagnostic test kits to healthcare professionals and nursing homes. This is great and it will be a key step for NG Biotech to get this going across the country.

www.eurobio-scientific.com/sites/default/files/PR_EUROBIO_NGBIOTECH_SEROLOGY_NCOV_EN.pdf

Its really up to you in how you view the company. You can go by share price movement or you can go by fundamentals. I personally go by fundamentals and have much more to confirm my confidence. Plus here is something so simple for anyone to understand. Atomo earned $883,302 revenue from sale of goods (notes in balance sheet) in Half yearly FY2020. If Atomo has already got 1.39M in orders from NG Biotech, will the revenue from these orders be greater or not greater?? I know the answer and it looks like Revenue GROWTH to me. Just need to be PATIENT

Expand

And the revenue doesn't include the sales relate to covid-19 per John Kelly in the webinar

AT1 Price at posting: 39.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

WGX

Westgold sets its sights on top five producer status through merger with Karora

GRX

GreenX picks up prospective copper project in Germany

There are more pages in this discussion • 1,059 more messages in this thread...

First 330 Last

Add AT1 (ASX) to my watchlist

(20min delay)
Last 2.4¢		Change 0.000(0.00%)		Mkt cap ! $15.34M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
3	497908	2.3¢

Sellers (Offers)

Price($)	Vol.	No.
2.5¢	67200	3

View Market Depth

No.	Vol.	Price($)
3	497908	0.023
6	725023	0.022
4	217292	0.021
2	250000	0.020
1	26316	0.019

Price($)	Vol.	No.
0.025	67200	3
0.026	390045	2
0.027	648550	3
0.028	155890	3
0.029	425248	5

Last trade - 16.12pm 02/08/2024 (20 minute delay)

AT1 (ASX) Chart

Day chart unavailable

And the revenue doesn't include the sales relate to covid-19 per...

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Venture to sniff out high-grade REE targets at Jupiter project, WA

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

GreenX picks up prospective copper project in Germany

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

And the revenue doesn't include the sales relate to covid-19 per...

Top Stories

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Venture to sniff out high-grade REE targets at Jupiter project, WA

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

GreenX picks up prospective copper project in Germany

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News